Washington Medicaid to Receive $660,500 in Settlement with GlaxoSmithKline
OLYMPIA – Attorney General Rob McKenna today announced that Washington’s Medicaid program will receive $660,500 as part of a national settlement with drug manufacturer GlaxoSmithKline. The settlement resolves allegations that the company improperly inflated the “average wholesale price” paid by government health plans for two prescription medications used to assist cancer patients undergoing chemotherapy.
Other Languages